Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 5, 2006

SAFC Bangalore Medicinal Chemistry Facility Inaugurated

  • SAFC’s pharma business segment opened a medicinal chemistry facility in Bangalore, India. The 139,000-sq-ft facility represents a $12-million investment and is considered a continuation of SAFC’s “build or acquire” strategy, put in place to meet the increased demands for its medicinal chemistry and cGMP manufacturing services.

    SAFC Bangalore features over 60,000 sq. ft. of production and R&D laboratory space, including manufacturing suites for chemical development and production to 50-L scale and an on-site warehouse.

    The operation offers a range of preclinical, process development, and scale-up services. Procedures are in place to work in alignment with SAFC’s Manchester, U.K., medicinal chemistry operations, ensure intellectual property protection, and to provide seamless technology transfer to SAFC manufacturing facilities worldwide.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »